Unknown

Dataset Information

0

Chimeric Peptides from Californiconus californicus and Heterodontus francisci with Antigen-Binding Capacity: A Conotoxin Scaffold to Create Non-Natural Antibodies (NoNaBodies).


ABSTRACT: Research into various proteins capable of blocking metabolic pathways has improved the detection and treatment of multiple pathologies associated with the malfunction and overexpression of different metabolites. However, antigen-binding proteins have limitations. To overcome the disadvantages of the available antigen-binding proteins, the present investigation aims to provide chimeric antigen-binding peptides by binding a complementarity-determining region 3 (CDR3) of variable domains of new antigen receptors (VNARs) with a conotoxin. Six non-natural antibodies (NoNaBodies) were obtained from the complexes of conotoxin cal14.1a with six CDR3s from the VNARs of Heterodontus francisci and two NoNaBodies from the VNARs of other shark species. The peptides cal_P98Y vs. vascular endothelial growth factor 165 (VEGF165), cal_T10 vs. transforming growth factor beta (TGF-β), and cal_CV043 vs. carcinoembryonic antigen (CEA) showed in-silico and in vitro recognition capacity. Likewise, cal_P98Y and cal_CV043 demonstrated the capacity to neutralize the antigens for which they were designed.

SUBMITTER: Duenas S 

PROVIDER: S-EPMC10141372 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chimeric Peptides from <i>Californiconus californicus</i> and <i>Heterodontus francisci</i> with Antigen-Binding Capacity: A Conotoxin Scaffold to Create Non-Natural Antibodies (NoNaBodies).

Dueñas Salvador S   Escalante Teresa T   Gasperin-Bulbarela Jahaziel J   Bernáldez-Sarabia Johanna J   Cervantes-Luévano Karla K   Jiménez Samanta S   Sánchez-Campos Noemí N   Cabanillas-Bernal Olivia O   Valdovinos-Navarro Blanca J BJ   Álvarez-Lee Angélica A   De León-Nava Marco A MA   Licea-Navarro Alexei F AF  

Toxins 20230404 4


Research into various proteins capable of blocking metabolic pathways has improved the detection and treatment of multiple pathologies associated with the malfunction and overexpression of different metabolites. However, antigen-binding proteins have limitations. To overcome the disadvantages of the available antigen-binding proteins, the present investigation aims to provide chimeric antigen-binding peptides by binding a complementarity-determining region 3 (CDR3) of variable domains of new ant  ...[more]

Similar Datasets

| S-EPMC7160280 | biostudies-literature
2026-01-31 | GSE314995 | GEO
| S-EPMC4412125 | biostudies-literature
| S-EPMC10413722 | biostudies-literature
| S-EPMC7720606 | biostudies-literature
| S-EPMC10029926 | biostudies-literature
| S-EPMC10691297 | biostudies-literature
| S-EPMC5496242 | biostudies-literature
| S-EPMC5604792 | biostudies-literature